A phase II study of cabozantinib and temozolomide in patients with unresectable or metastatic leiomyosarcoma and other soft tissue sarcomas

被引：0
|
作者：
Agulnik, Mark
Okuno, Scott H.
Van Tine, Brian Andrew
Pollack, Seth
Weiss, Mia C.
Hirbe, Angela C.
Viveiros, Pedro
Schulte, Brian
Frankel, Paul Henry
Attia, Steven
Siontis, Brittany L.
Milhem, Mohammed M.
Monga, Varun
Charlson, John A.
Robinson, Steven Ian
Yoon, Janet
机构：
[1] City Hope Comprehens Canc Ctr, Durarte, CA USA
[2] Mayo Clin, Rochester, MN USA
[3] Washington Univ St Louis, St Louis, MO USA
[4] Northwestern Univ, Chicago, IL USA
[5] Washington Univ, Sch Med, St Louis, MO USA
[6] UCSF Helen Diller Family Comprehens Canc Ctr, San Francisco, CA USA
[7] Mayo Clin, Jacksonville, FL USA
[8] Univ Iowa, Holden Comprehens Canc Ctr, Iowa City, IA USA
[9] Univ Iowa, Iowa City, IA USA
[10] Med Coll Wisconsin, Milwaukee, WI USA
[11] City Hope Natl Med Ctr, Duarte, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
11505
引用
下载
收藏
页数：1
相关论文
共 50 条
  • [41] A phase II study of ipilimumab plus temozolomide in patients with metastatic melanoma
    Sapna P. Patel
    Dae Won Kim
    Roland L. Bassett
    Suzanne Cain
    Edwina Washington
    Wen-Jen Hwu
    Kevin B. Kim
    Nicholas E. Papadopoulos
    Jade Homsi
    Patrick Hwu
    Agop Y. Bedikian
    Cancer Immunology, Immunotherapy, 2017, 66 : 1359 - 1366
  • [42] Electrochemotherapy Treatment of Locally Advanced and Metastatic Soft Tissue Sarcomas: Results of a Non-Comparative Phase II Study
    Luca G. Campana
    Giuseppe Bianchi
    Simone Mocellin
    Sara Valpione
    Laura Campanacci
    Antonella Brunello
    Davide Donati
    Elisabetta Sieni
    Carlo R. Rossi
    World Journal of Surgery, 2014, 38 : 813 - 822
  • [43] A phase II study of ipilimumab plus temozolomide in patients with metastatic melanoma
    Patel, Sapna P.
    Kim, Dae Won
    Bassett, Roland L.
    Cain, Suzanne
    Washington, Edwina
    Hwu, Wen-Jen
    Kim, Kevin B.
    Papadopoulos, Nicholas E.
    Homsi, Jade
    Hwu, Patrick
    Bedikian, Agop Y.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2017, 66 (10) : 1359 - 1366
  • [44] Electrochemotherapy Treatment of Locally Advanced and Metastatic Soft Tissue Sarcomas: Results of a Non-Comparative Phase II Study
    Campana, Luca G.
    Bianchi, Giuseppe
    Mocellin, Simone
    Valpione, Sara
    Campanacci, Laura
    Brunello, Antonella
    Donati, Davide
    Sieni, Elisabetta
    Rossi, Carlo R.
    WORLD JOURNAL OF SURGERY, 2014, 38 (04) : 813 - 822
  • [45] Phase II study of the antiangiogenic agent SU5416 in patients with advanced soft tissue sarcomas
    Heymach, JV
    Desai, J
    Manola, J
    Davis, DW
    McConkey, DJ
    Harmon, D
    Ryan, DP
    Goss, G
    Quigley, T
    Van den Abbeele, AD
    Silverman, SG
    Connors, S
    Folkman, J
    Fletcher, CDM
    Demetri, GD
    CLINICAL CANCER RESEARCH, 2004, 10 (17) : 5732 - 5740
  • [46] A phase II study of aflibercept (VEGF trap) in recurrent or metastatic gynecologic soft-tissue sarcomas: A study of the Princess Margaret Hospital Phase II Consortium
    Townsley, C.
    Hirte, H.
    Hoskins, P.
    Buckanovich, R.
    Mackay, H.
    Welch, S.
    Wang, L.
    Polintan, R.
    Chen, A.
    Oza, A. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [47] A phase II study of temsirolimus and liposomal doxorubicin for patients with recurrent and refractory bone and soft tissue sarcomas
    Trucco, Matteo M.
    Meyer, Christian F.
    Thornton, Katherine A.
    Shah, Preeti
    Chen, Allen R.
    Wilky, Breelyn A.
    Carrera-Haro, Maria A.
    Boyer, Lillian C.
    Ferreira, Margaret F.
    Shafique, Umber
    Powell, Jonathan D.
    Loeb, David M.
    CLINICAL SARCOMA RESEARCH, 2018, 8
  • [48] Phase II Trial of Topotecan by Continuous Infusion in Patients with Advanced Soft Tissue Sarcomas, a SWOG Study
    G. Thomas Budd
    Cathryn Rankin
    Laura F. Hutchins
    Lucas Wong
    Paul J. Petruska
    Karen Antman
    Investigational New Drugs, 2002, 20 : 129 - 132
  • [49] Phase II trial of topotecan by continuous infusion in patients with advanced soft tissue sarcomas, a SWOG study
    Budd, GT
    Rankin, C
    Hutchins, LF
    Wong, L
    Petruska, PJ
    Antman, K
    INVESTIGATIONAL NEW DRUGS, 2002, 20 (01) : 129 - 132
  • [50] A phase II trial of temozolomide as a 6-week, continuous, oral schedule in patients with advanced soft tissue sarcoma - A study by the Spanish group for research on sarcomas
    del Muro, XG
    Lopez-Pousa, A
    Martin, J
    Buesa, JM
    Martinez-Trufero, J
    Casado, A
    Poveda, A
    Cruz, J
    Bover, I
    Maurel, J
    CANCER, 2005, 104 (08) : 1706 - 1712
12345